期刊文献+

无抽搐电痉挛治疗难治性抑郁症33例效果观察及护理 被引量:6

Observation on the effect of modified ECT in the treatment of 33 patients with refractory depression and nursing care
下载PDF
导出
摘要 目的:探讨无抽搐电痉挛治疗难治性抑郁症的效果及护理方法。方法:将65例难治性抑郁症患者随机分为两组,研究组33例采用无抽搐电痉挛治疗,对照组32例采用传统抗抑郁药物治疗。共观察4周,在治疗前及治疗第1周末、第2周末、第4周末分别采用汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)、副反应量表(TESS)评定疗效及不良反应。结果:治疗第1周末、第2周末及第4周末,研究组HAMD及HAMA评分均显著低于对照组,差异均有显著性(P(0.05)。研究组未出现严重不良反应。结论:无抽搐电痉挛治疗配合有效的护理是治疗难治性抑郁症快速、有效、安全的首选方法之一。 Objective : To discuss the effect of modified electroconvulsive therapy (ECT) and nursing methods in the treat- ment of refractory depression. Methods : 65 patients with refractory depression were randomly divided into study group ( n = 33 ) and control group I n = 32 ). Modified ECT was applied in study group and traditional antidepressant medication was used in control group. Hamilton Depression Rating Scale ( HAMD ), Hamilton Anxiety Rating Scale ( HAMA ) and Treatment Emergent Symptom Scale ( TESS ) were adopted to respectively assess the efficacy and adverse reactions before treatment and at the end of the first, second and fourth week. Results : The scores of HAMD and HAMA in study group were significantly lower than that in control group at the end of 1st, 2nd and 4th week after treatment ( P 〈 0.05 ). No serious adverse reactions occurred in study group. Conclusion : Modified ECT combined with effective nursing care is one of fast, effective, safe and preferred therapies in the treatment of refractory depression.
作者 王莉萍
出处 《齐鲁护理杂志》 2009年第8期8-10,共3页 Journal of Qilu Nursing
关键词 无抽搐电痉挛治疗 难治性抑郁症 护理 Modified ECT Refractory depression Nursing
  • 相关文献

参考文献13

二级参考文献51

  • 1沈一峰,李华芳,马崔,陈远光,范俭雄,蓝长安,程能能,顾牛范.瑞波西汀与氟西汀治疗抑郁症随机双盲多中心临床研究[J].中国新药与临床杂志,2005,24(8):619-623. 被引量:10
  • 2[4]Montgomery S.Fergusom JM,Schwartz GE.The antidepres-sant efficacy of rebxetine in patients with severe depression[J].J Clin Psychopharmacol,2003,23(1):45~50
  • 3[5]Andreoliv.CaillardV,Deo RS,et al.Reboxetine,a new nora-drenaline selective antidepressant is at least as effective as fluoxetine in the treatment of depression[J].J Clin Psychopharrnacol,2002,22(4):393~399
  • 4[6]VendittiLN,Arcelus A,Birnbaum H,et al.The impact of antidepressant use on social functioning reboxetine versus fluoxetine[J].Int Clin Psychopharmacol,2000,15(5):279~289
  • 5[7]VersianiM,AminM,Chouinard G.Double-blind,placebo controlled study with reboxetine in inpatients with severe major depressive disorder[J].J Clin Psychopharmacol,2000,20(1):28~34
  • 6[8]Nelson JC,Portera L,Leon AC.Are there differences in the symptoms that respond to a selective serotonin or norepinepbrine reuptake inhibitor[J]? Biol Psychiatry,2005,57(15):1535~1542
  • 7[9]Messer T,Schmauss M,Lambert-Baumann J.Efficacy and tolerability of reboxetine in depressive patients treated in routine clinical practice[J].CNS Drugs,2005,19:43~54
  • 8[10]Almasi J,Rihmer Z.Review of antidepressants from the TCAs to the third generation drugs[J].Neuropsychopharmacol Hung,2004,6:185~94
  • 9[11]Bodlund O,Haggstrom L.SSRI resistant depression.Supplementation with noradren-ergic pharmaceuticals can be a good alternative[J].Lakartidningen,2004,101:2712~2714
  • 10[12]Baldwin D,Bridgman K,Buis C.Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine[J].J Psychopharmacol,2006,20:91~96

共引文献1012

同被引文献65

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部